• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个体患者数据共享时代的随机临床试验的荟萃分析。

Meta-analysis of randomized clinical trials in the era of individual patient data sharing.

机构信息

Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Annex of Bldg. 3, 5th Floor, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.

Astellas Pharma Inc., Tokyo, 2-5-1 Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8411, Japan.

出版信息

Int J Clin Oncol. 2018 Jun;23(3):403-409. doi: 10.1007/s10147-018-1237-z. Epub 2018 Jan 12.

DOI:10.1007/s10147-018-1237-z
PMID:29330642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5951901/
Abstract

BACKGROUND

Individual patient data (IPD) meta-analysis is considered to be a gold standard when the results of several randomized trials are combined. Recent initiatives on sharing IPD from clinical trials offer unprecedented opportunities for using such data in IPD meta-analyses.

METHODS

First, we discuss the evidence generated and the benefits obtained by a long-established prospective IPD meta-analysis in early breast cancer. Next, we discuss a data-sharing system that has been adopted by several pharmaceutical sponsors. We review a number of retrospective IPD meta-analyses that have already been proposed using this data-sharing system. Finally, we discuss the role of data sharing in IPD meta-analysis in the future.

RESULTS

Treatment effects can be more reliably estimated in both types of IPD meta-analyses than with summary statistics extracted from published papers. Specifically, with rich covariate information available on each patient, prognostic and predictive factors can be identified or confirmed. Also, when several endpoints are available, surrogate endpoints can be assessed statistically.

CONCLUSIONS

Although there are difficulties in conducting, analyzing, and interpreting retrospective IPD meta-analysis utilizing the currently available data-sharing systems, data sharing will play an important role in IPD meta-analysis in the future.

摘要

背景

当合并几项随机试验的结果时,个体患者数据(IPD)荟萃分析被认为是金标准。最近关于分享临床试验 IPD 的倡议为在 IPD 荟萃分析中使用此类数据提供了前所未有的机会。

方法

首先,我们讨论了一项长期前瞻性 IPD 荟萃分析在早期乳腺癌中产生的证据和获得的益处。接下来,我们讨论了几个制药赞助商采用的数据共享系统。我们回顾了已经使用该数据共享系统提出的一些回顾性 IPD 荟萃分析。最后,我们讨论了未来数据共享在 IPD 荟萃分析中的作用。

结果

在这两种类型的 IPD 荟萃分析中,治疗效果的估计比从已发表论文中提取的汇总统计数据更可靠。具体来说,通过对每个患者的丰富协变量信息,可识别或确认预后和预测因素。此外,当有多个终点时,可以对替代终点进行统计学评估。

结论

尽管利用现有的数据共享系统进行回顾性 IPD 荟萃分析存在困难,但在未来,数据共享将在 IPD 荟萃分析中发挥重要作用。

相似文献

1
Meta-analysis of randomized clinical trials in the era of individual patient data sharing.个体患者数据共享时代的随机临床试验的荟萃分析。
Int J Clin Oncol. 2018 Jun;23(3):403-409. doi: 10.1007/s10147-018-1237-z. Epub 2018 Jan 12.
2
Feasibility of individual patient data meta-analyses in orthopaedic surgery.骨科手术中个体患者数据荟萃分析的可行性
BMC Med. 2015 Jun 3;13:131. doi: 10.1186/s12916-015-0376-6.
3
The project data sphere initiative: accelerating cancer research by sharing data.项目数据领域计划:通过数据共享加速癌症研究
Oncologist. 2015 May;20(5):464-e20. doi: 10.1634/theoncologist.2014-0431. Epub 2015 Apr 15.
4
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.来自随机试验的个体患者数据的Meta分析:实践中使用方法的综述
Clin Trials. 2005;2(3):209-17. doi: 10.1191/1740774505cn087oa.
5
A data-sharing agreement helps to increase researchers' willingness to share primary data: results from a randomized controlled trial.数据共享协议有助于提高研究人员分享原始数据的意愿:一项随机对照试验的结果。
J Clin Epidemiol. 2019 Feb;106:60-69. doi: 10.1016/j.jclinepi.2018.10.006. Epub 2018 Oct 19.
6
Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide.个体参与者数据荟萃分析中获取和管理数据集:范围综述与实用指南。
BMC Med Res Methodol. 2020 May 12;20(1):113. doi: 10.1186/s12874-020-00964-6.
7
Meta-analysis of continuous outcomes combining individual patient data and aggregate data.结合个体患者数据和汇总数据对连续性结局进行Meta分析。
Stat Med. 2008 May 20;27(11):1870-93. doi: 10.1002/sim.3165.
8
Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials.混合治疗比较荟萃分析中结合个体患者数据和汇总数据:如果仅对一部分试验而言,个体患者数据可能是有益的。
Stat Med. 2013 Mar 15;32(6):914-30. doi: 10.1002/sim.5584. Epub 2012 Sep 17.
9
Meta-analysis using individual participant data from randomised trials: opportunities and limitations created by access to raw data.使用随机试验个体参与者数据的Meta分析:获取原始数据所带来的机遇与局限
Evid Based Med. 2017 Oct;22(5):157-162. doi: 10.1136/ebmed-2017-110775. Epub 2017 Aug 17.
10
Data sharing: experience of accessing individual patient data from completed randomised controlled trials in vascular and cognitive medicine.数据共享:从已完成的血管与认知医学随机对照试验中获取个体患者数据的经验
BMJ Open. 2020 Sep 9;10(9):e038765. doi: 10.1136/bmjopen-2020-038765.

引用本文的文献

1
Advancing the role of real-world evidence in comparative effectiveness research.推进真实世界证据在药物比较有效性研究中的作用。
J Comp Eff Res. 2024 Dec;13(12):e240101. doi: 10.57264/cer-2024-0101. Epub 2024 Oct 11.
2
Sharing individual participant data: through a systematic reviewer lens.分享个体参与者数据:从系统评价者的视角。
Trials. 2022 Feb 21;23(1):167. doi: 10.1186/s13063-021-05787-4.
3
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology.转移性癌症临床试验终点:利用个体参与者数据为未来试验方法学提供信息。
J Natl Cancer Inst. 2022 Jun 13;114(6):819-828. doi: 10.1093/jnci/djab218.
4
CONSIDER Statement: Consolidated Recommendations for Sharing Individual Participant Data from Human Clinical Studies.CONSIDER 声明:从人体临床研究中共享个体参与者数据的综合建议。
AMIA Jt Summits Transl Sci Proc. 2021 May 17;2021:438-444. eCollection 2021.
5
Status, use and impact of sharing individual participant data from clinical trials: a scoping review.临床试验个体参与者数据共享的现状、使用和影响:范围综述。
BMJ Open. 2021 Aug 18;11(8):e049228. doi: 10.1136/bmjopen-2021-049228.
6
Open Data Revolution in Clinical Research: Opportunities and Challenges.临床研究中的开放数据革命:机遇与挑战。
Clin Transl Sci. 2020 Jul;13(4):665-674. doi: 10.1111/cts.12756. Epub 2020 Mar 10.
7
Evaluation of repositories for sharing individual-participant data from clinical studies.用于共享临床研究中个体参与者数据的储存库评估。
Trials. 2019 Mar 15;20(1):169. doi: 10.1186/s13063-019-3253-3.

本文引用的文献

1
Prevalence and decay of maternal pneumococcal and meningococcal antibodies: A meta-analysis of type-specific decay rates.孕产妇肺炎球菌和脑膜炎球菌抗体的流行率及衰减情况:特定类型衰减率的荟萃分析
Vaccine. 2017 Oct 13;35(43):5850-5857. doi: 10.1016/j.vaccine.2017.09.002. Epub 2017 Sep 19.
2
Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors.临床试验数据共享声明:医学期刊编辑国际委员会的一项要求。
JAMA. 2017 Jun 27;317(24):2491-2492. doi: 10.1001/jama.2017.6514.
3
The Influence of Maternally Derived Antibody and Infant Age at Vaccination on Infant Vaccine Responses : An Individual Participant Meta-analysis.母源抗体和婴儿接种疫苗时的年龄对婴儿疫苗反应的影响:一项个体参与者荟萃分析。
JAMA Pediatr. 2017 Jul 1;171(7):637-646. doi: 10.1001/jamapediatrics.2017.0638.
4
Exploring changes over time and characteristics associated with data retrieval across individual participant data meta-analyses: systematic review.探索个体参与者数据荟萃分析中随时间的变化以及与数据检索相关的特征:系统评价。
BMJ. 2017 Apr 5;357:j1390. doi: 10.1136/bmj.j1390.
5
Data Sharing - Is the Juice Worth the Squeeze?数据共享——挤出来的汁值得吗?
N Engl J Med. 2016 Oct 27;375(17):1608-1609. doi: 10.1056/NEJMp1610336.
6
Data Sharing at a Crossroads.数据共享处于十字路口。
N Engl J Med. 2016 Sep 22;375(12):1115-7. doi: 10.1056/NEJMp1608086.
7
Incentives for Clinical Trialists to Share Data.鼓励临床试验人员共享数据的激励措施。
N Engl J Med. 2016 Sep 22;375(12):1112-5. doi: 10.1056/NEJMp1608351.
8
Assessing sex-differences and the effect of timing of vaccination on immunogenicity, reactogenicity and efficacy of vaccines in young children: study protocol for an individual participant data meta-analysis of randomised controlled trials.评估幼儿疫苗接种时间对疫苗免疫原性、反应原性和效力的性别差异及影响:一项随机对照试验个体参与者数据荟萃分析的研究方案
BMJ Open. 2016 Jul 29;6(7):e011680. doi: 10.1136/bmjopen-2016-011680.
9
A Global, Neutral Platform for Sharing Trial Data.一个用于共享试验数据的全球中立平台。
N Engl J Med. 2016 Jun 23;374(25):2411-3. doi: 10.1056/NEJMp1605348. Epub 2016 May 11.
10
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol.肝素在癌症患者中的应用:随机试验的个体参与者数据荟萃分析研究方案
BMJ Open. 2016 Apr 29;6(4):e010569. doi: 10.1136/bmjopen-2015-010569.